Seroepidemiology of EBV and Interpretation of the "Isolated VCA IgG" Pattern

被引:32
|
作者
De Paschale, Massimo [1 ]
Agrappi, Carlo [1 ]
Manco, Maria Teresa [1 ]
Mirri, Paola [1 ]
Vigano, Egidio Franco [1 ]
Clerici, Pierangelo [1 ]
机构
[1] Hosp Legnano, Microbiol Unit, I-20025 Milan, Italy
关键词
ELISA; immunoblotting; mononucleosis; serological pattern; EPSTEIN-BARR-VIRUS; NUCLEAR ANTIGEN; INFECTION; ANTIBODY; GLYCOPROTEIN; DIAGNOSIS; ASSAYS;
D O I
10.1002/jmv.21373
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The presence of VCA IgG in the absence of VCA IgM and EBNA-1 IgG antibodies makes classifying EBV infection more difficult as this serological picture can be seen in the case of past infection with EBNA-1 IgG loss or non-appearance, or acute infections with the early disappearance or delayed onset of VCA IgM. The aim of this study was to assess the prevalence of this pattern in 2,422 outpatients with suspected EBV infection examined in 2005-2006, and to interpret its significance by means of immunoblotting. One hundred and seventy-seven (7.3%) of the patients were VCA IgG-positive, VCA IgM-negative and EBNA-1 IgG-negative, 15 of whom (8.5%) presented with heterophile antibodies. Analysis by age class showed that the prevalence of isolated VCA IgG ranged from 4.5% in the subjects aged 1-10 years to 9% in those aged > 60 years. Immunoblotting allowed 18.9% of the cases to be classified as acute and 81.1% as past infections, the latter being observed in about 37% of the patients aged less than 10 years and in 100% of those aged > 30 years. Therefore, in our case series, the presence of isolated VCA IgG was associated usually with past infection, particularly among adults. In children aged less than 10 years, it was associated mainly with acute infection but as past infection may be present in about one-third of such children, this possibility should not be overlooked. J. Med. Virol. 81:325-331, 2009. (c) 2008 Wiley-Liss, Inc.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 50 条
  • [1] Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation
    Maylin, Sarah
    Feghoul, Linda
    Salmona, Maud
    Herda, Adel
    Mercier-Delarue, Severine
    Simon, Francois
    Legoff, Jerome
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (11) : 2003 - 2010
  • [2] Performance Evaluation of IMMULITE® 2000 EBV-VCA IgG, EBV-VCA IgM, and EBV-EBNA IgG Assays from Siemens Healthcare Diagnostics
    Lee, C. C.
    Kode, S.
    Dykheng, J.
    Chuu, C.
    Zhao, A.
    Koussa, R.
    Cervante, C.
    Sustarsic, D.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A150 - A151
  • [3] Comparative study between the new VIDAS® EBV VCA IgM, VCA/EA IgG and EBNA IgG tests and Liaison EBV tests for the diagnosis of infectious mononucleosis
    Baccard, M.
    Foussadier, A.
    Allard, L.
    Desmottes, P.
    Bridon, L.
    Morand, P.
    Seigneurin, J. M.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S56 - S56
  • [4] COMPARISON OF THE ARCHITECT VCA-IGM, VCA-IGG, AND EBNA IGG PROTOTYPE ASSAYS TO THE DIASORIN LIAISON EBV PANEL
    Braun, H. B.
    Berger, M.
    Bernhardt, S.
    Berghaus, S.
    Sickinger, E.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S518 - S518
  • [5] EBV-VCA-IgG检测的临床诊断意义
    陆建国
    肖荣
    实用预防医学, 2006, (04) : 1014 - 1015
  • [6] Evaluation of the Architect Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG, VCA IgM, and EBV Nuclear Antigen 1 IgG Chemiluminescent Immunoassays for Detection of EBV Antibodies and Categorization of EBV Infection Status Using Immunofluorescence Assays as the Reference Method
    Corrales, Isabel
    Gimenez, Estela
    Navarro, David
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (05) : 684 - 688
  • [7] Familial correlations of anti-VCA IgG titers in families with EBV related lymphoproliferations
    Besson, C.
    Amiel, C.
    Le-Pendeven, C.
    Plancoulaine, S.
    Bonnardel, C.
    Ranque, B.
    Brice, P.
    Ferme, C. H.
    Carde, P.
    Hermine, O.
    Bresson, J. L.
    Nicolas, J. C.
    Gessain, A.
    de The, G.
    Abel, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 35 - 35
  • [8] Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection
    Robertson, P
    Beynon, S
    Whybin, R
    Brennan, C
    Vollmer-Conna, U
    Hickie, I
    Lloyd, A
    JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (04) : 617 - 623
  • [9] Comparison of SIEMENS IMMULITE® 2000 with GenBio immunowell EIA for detection of antibodies to EBV VCA IgG & IgM and EBNA IgG
    Lee, C.
    Conde, M.
    Chuu, C.
    Ghadessi, M.
    Lei, J.
    Sustarsic, D.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A58 - A59
  • [10] About the clinical benefits of EBV markers (EA IgG, VCA IGM, VCA IgG and EBNA IgG) in the diagnosis of infectious mononucleosis diagnosis: comparative responses of 2 automated methods VIDAS and Liaison
    Foussadier, A.
    Allard, L.
    Desmottes, P.
    Bridon, L.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S49 - S50